Walter V Klemp, CEO and President at Moleculin Biotech, bought MBRX on Aug 3, 2026
Prices as of Oct 16 · price update delayed · Every feed →
- Traded
- Aug 3, 2026
- Disclosed
- Aug 5, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MBRX since disclosure
−28.1%
Similar stocks (XLV) since disclosure
+7.6%
XLV — its sector index fund
Change in closing price from Aug 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
- Not enough evidence · In past tests: 5.6 percentage points better than similar stocks over 3 months · 5,663 tries